For early-stage pharma and biotech companies, comprehensive
intellectual property (IP) strategies do more than protect
innovation. They set the stage for your company's long-term
success – helping raise funds, attract partners and expand
into new markets.
Our Vancouver IP Group has created a three-part video series to
provide early-stage life sciences companies with the resources they
need to ensure their IP assets are protected in a highly
competitive market.
IP assets
Mark Wilke, partner and patent agent, gives an
introduction into the various IP assets – patents, industrial
designs/design patents, trademarks, copyrights and trade secrets
– that are fundamental for life sciences companies.
